46 results
8-K
ZOM
Zomedica Corp
28 Nov 18
Zomedica Signs Exclusive Agreement with Qorvo Biotechnologies for Global Veterinary Rights to Diagnostic Point-of-Care Platform
6:53am
development work initially targets five assay cartridge candidates to detect thyroid and adrenal disorders in dogs and cats, which currently require
8-K
ZOM
Zomedica Corp
17 Jun 20
Departure of Directors or Certain Officers
4:46pm
and the remaining options to purchase 1,333,333 common shares will vest, if at all, upon the achievement of certain performance targets. The options
8-K
ZOM
Zomedica Corp
13 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
distribution targets, including maintaining a minimum amount of shareholders’ equity and a minimum number of public shareholders. In addition
8-K
EX-99.1
ZOM
Zomedica Corp
28 Nov 18
Zomedica Signs Exclusive Agreement with Qorvo Biotechnologies for Global Veterinary Rights to Diagnostic Point-of-Care Platform
6:53am
at the point of care. The joint development work initially targets five assay cartridge candidates to detect the following thyroid and adrenal disorders
8-K
EX-99.1
ZOM
Zomedica Corp
20 Dec 18
Other Events
5:06pm
utility in other veterinary diagnostic areas such as molecular diagnostics and multiplexing capabilities. The joint development work initially targets … targets five assay cartridge candidates to detect the thyroid and adrenal disorders in dogs and cats. Qorvo is responsible for the development
424B4
4yfchdpg3ss7of8
27 May 20
Prospectus supplement with pricing info
4:09pm
424B4
zru zznf716vxbgedfkr
26 Jun 20
Prospectus supplement with pricing info
4:28pm
PRE 14A
z0mi49wwvkb jdg0iqd
29 Jul 20
Preliminary proxy
5:25pm